KDAc Therapeutics, Inc.
Biotech · Private
Selective HDAC6 inhibitor small molecules for PTSD treatment
- Grants
- $605K
- 2 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 3
- 1 granted · 2 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20152016
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Small Molecule Selective HDAC3 Inhibitors as a Novel Therapy for PTSD | $379,712 | |
| Federal grant | Department of Health and Human Services · Phase I · Selective HDAC3 Inhibitors as a Novel Therapy for Drug Addiction | $225,000 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1838 | CONCEPTION HOLDINGS, INC. | — | $50K |
| 1839 | TRANSLATIONAL SCIENCES INC. | — | — |
| 1840 | Entelo, Inc. | — | $4.9M |
| 1841 | KDAc Therapeutics, Inc. | — | — |
| 1842 | SCRIPT BIOSCIENCES INC | — | — |
| 1843 | HCO ANTIBODY, INC. | — | — |
| 1844 | MARIPOSA HOLDINGS GROUP, INC. | — | $280K |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Combination Of A Selective Histone Deacetylase 3 (HDAC3) Inhibitor And An Immunotherapy Agent For The Treatment Of Cancerapplication
- Combination Of A Selective Histone Deacetylase 3 (HDAC3) Inhibitor And An Immunotherapy Agent For The Treatment Of Cancergranted
- Combination Of A Selective Histone Deacetylase 3 (HDAC3) Inhibitor And An Immunotherapy Agent For Treatment Of Cancerapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.